Prediction of Disease Progression in Primary Progressive Multiple Sclerosis

被引:0
|
作者
Patrucco, Liliana
Ignacio Rojas, Juan
Cristiano, Edgardo
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A69 / A69
页数:1
相关论文
共 50 条
  • [21] Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Montalban, Xavier
    Wolinsky, Jerry
    Kappos, Ludwig
    Hauser, Stephen L.
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bernasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, P.
    Belachew, S.
    Arnold, D. L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP10 - NP10
  • [22] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Montalban, X.
    Wolinsky, J.
    Kappos, L.
    Hauser, S. L.
    Giovannoni, G.
    de Seze, J.
    Bar-or, A.
    Masterman, D.
    Bernasconi, C.
    Wei, W.
    Garren, H.
    Chin, P.
    Belachew, S.
    Arnold, D. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 576 - 576
  • [23] EVALUATION OF NO EVIDENCE OF PROGRESSION OR ACTIVE DISEASE (NEPAD) IN PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN THE ORATORIO TRIAL
    Wolinsky, Jerry
    Montalban, Xavier
    Kappos, Ludwig
    Hauser, Stephen
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bernasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Arnold, Doug L.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):
  • [24] Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Wolinsky, Jerry S.
    Montalban, Xavier
    Hauser, Stephen L.
    Giovannoni, Gavin
    Vermersch, Patrick
    Bernasconi, Corrado
    Deol-Bhullar, Gurpreet
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Kappos, Ludwig
    ANNALS OF NEUROLOGY, 2018, 84 (04) : 527 - 536
  • [25] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Primary Progressive Multiple Sclerosis in the ORATORIO Trial
    Wolinsky, Jerry
    Montalban, Xavier
    Kappos, Ludwig
    Hauser, Stephen
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bemasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Arnold, Douglas
    NEUROLOGY, 2017, 88
  • [26] Disease onset in familial and sporadic primary progressive multiple sclerosis
    Koch, M.
    Zhao, Y.
    Yee, I.
    Guimond, C.
    Kingwell, E.
    Rieckmann, P.
    Sadovnick, D.
    Tremlett, H.
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (06) : 694 - 700
  • [27] Clinical predictors of disease progression in a cohort of Tunisian progressive Multiple Sclerosis
    Souissi, A.
    Mrabet, S.
    Nasri, A.
    Ben Djebara, M.
    Gargouri, A.
    Kacem, I.
    Gouider, R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [28] Disease course in primary progressive multiple sclerosis: validation of a prediction model using multimodal evoked potentials
    Hardmeier, M.
    Schlaeger, R.
    Lascano, A. M.
    Toffolet, L.
    Schindler, C.
    Gobbi, C.
    Lalive, P.
    Kuhle, J.
    Kappos, L.
    Fuhr, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 153 - 154
  • [29] Prediction of disease progression and outcomes in multiple sclerosis with machine learning
    Pinto, Mauro F.
    Oliveira, Hugo
    Batista, Sonia
    Cruz, Luis
    Pinto, Mafalda
    Correia, Ines
    Martins, Pedro
    Teixeira, Cesar
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [30] Prediction of disease progression and outcomes in multiple sclerosis with machine learning
    Mauro F. Pinto
    Hugo Oliveira
    Sónia Batista
    Luís Cruz
    Mafalda Pinto
    Inês Correia
    Pedro Martins
    César Teixeira
    Scientific Reports, 10